Formula Growth’s CareDx CDNA Stock Holding History

Formula Growth’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.22M	Sell	78,026 -452	-0.6%	-$9.84K	0.78%	43
2026 Q1	$1.36M	Sell	78,478 -22,190	-22%	-$420K	0.61%	60
2025 Q4	$1.9M	Sell	100,668 -91,625	-48%	-$1.53M	0.73%	52
2025 Q3	$2.8M	Hold	192,293	–	–	0.99%	40
2025 Q2	$3.76M	Buy	192,293 +44,084	+30%	+$783K	1.42%	15
2025 Q1	$2.63M	Buy	148,209 +70,209	+90%	+$1.51M	1.07%	38
2024 Q4	$1.67M	Buy	+78,000	New	+$1.9M	0.57%	70
2022 Q4	–	Sell	-157,681	Closed	-$2.68M	–	135
2022 Q3	$2.68M	Buy	157,681 +46,077	+41%	+$989K	0.77%	55
2022 Q2	$2.4M	Hold	111,604	–	–	0.66%	59
2022 Q1	$4.13M	Sell	111,604 -2,184	-2%	-$85.1K	0.78%	50
2021 Q4	$5.17M	Buy	113,788 +78,288	+221%	+$4.09M	0.92%	35
2021 Q3	$2.25M	Hold	35,500	–	–	0.32%	92
2021 Q2	$3.25M	Hold	35,500	–	–	0.45%	73
2021 Q1	$2.42M	Hold	35,500	–	–	0.35%	85
2020 Q4	$2.57M	Sell	35,500 -9,500	-21%	-$550K	0.43%	68
2020 Q3	$1.71M	Buy	45,000 +10,000	+29%	+$338K	0.32%	90
2020 Q2	$1.24M	Buy	+35,000	New	+$996K	0.21%	101

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Formula Growth's CDNA Position: Q2 2026 in Review

Formula Growth reduced its CareDx (CDNA) stake by 0.58% in Q2 2026, selling an estimated $9.84K and leaving 78,026 shares worth $2.22M. The position accounts for 0.78% of the portfolio, ranked #43.

Formula Growth first reported a position in CDNA in Q2 2020 and has held it in 17 quarters since. The position peaked at $5.17M in Q4 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Formula Growth held 78,026 shares of CareDx worth $2.22M as of Q2 2026.
Formula Growth sold 452 CareDx shares in Q2 2026, an estimated $9.84K.
CareDx made up 0.78% of Formula Growth's portfolio in Q2 2026, its #43 holding.
Formula Growth first reported a position in CareDx in Q2 2020 and has held it in 17 quarters since.
Formula Growth's CareDx position peaked at $5.17M in Q4 2021.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.